Tips, insights, and expert advice to help you manage brain and eye disease.
Our tools will help you understand and manage symptoms, treatment, and prevention of these diseases.
Neurofibrillary tangles associated with Alzheimer's disease consist primarily of a protein called tau. Learn more about research into tau and Alzheimer’s.
Medical marijuana has been shown to lower eye pressure, a key factor in glaucoma. But is it safe to use?
This article explores what Medicare covers, with a special note about long-term care and assisted living.
Doctors who prescribe Leqembi, a new FDA-approved Alzheimer’s disease drug, are required to enroll their patients in a registry to obtain Medicare insurance coverage. Here are six facts to know about patient registries, including how your privacy is protected.
Learn helpful caregiver tips for the holiday season.
Leqembi, an amyloid-clearing drug that's received full approval from the FDA, is offering renewed hope to people with early signs of dementia. Here’s what to know about it.
New research has shed light on the connection between ADHD and Alzheimer’s, including a first-of-its-kind study that suggests people who had ADHD as children may be more likely to develop Alzheimer’s as adults.
African Americans and Hispanics are at increased risk of developing glaucoma. Find out why and learn about important steps that can prevent vision loss from this eye disease.
Learn about the various forms of childhood glaucoma, as well the associated risk factors, examination procedures, and treatments.
Recent research has opened avenues to our understanding of the underlying genetics of common forms of adult-onset glaucoma. However, it is not as straightforward as a single gene mutation leading to glaucoma.